Doherty researchers develop world-first AMR detection tool
A new tool that could soon revolutionise the way we identify antimicrobial resistance (AMR) has been developed by researchers at the University of Melbourne’s Microbiological Diagnostic Unit Public Health Laboratory (MDU PHL), located at the Peter Doherty Institute for Infection and Immunity (Doherty Institute).
abritAMR is an ISO-certified bioinformatics platform that is able to find AMR determinants from whole genome sequencing data and separates the identified genes into functionally relevant groups.
To date, the lack of international standards in the AMR genomics space has been a limiting factor in the ability to compare outputs from different laboratories, especially with regards to how that information is applied in the clinical context.
OUR UNDERWRITERS
Unrestricted financial support by:
 |
Antimicrobial Resistance Fighter Coalition |
 |
Bangalore Bioinnovation Centre |
 |
INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS |
 |
BD |
AMR NEWS
Your Biweekly Source for Global AMR Insights!
Stay informed with the essential newsletter that brings together all the latest One Health news on antimicrobial resistance. Delivered straight to your inbox every two weeks, AMR NEWS provides a curated selection of international insights, key publications, and the latest updates in the fight against AMR.
Don’t miss out on staying ahead in the global AMR movement—subscribe now!